发明授权
- 专利标题: Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
-
申请号: US15327517申请日: 2015-07-24
-
公开(公告)号: US10752668B2公开(公告)日: 2020-08-25
- 发明人: Sophie Agaugue , Lorenzo Tibaldi , Klervi Even-Desrumaux , Dmitry Trubetskoy , Franck Perez , Sebastian Amigorena , Cécile Bauche
- 申请人: THERAVECTYS , INSTITUT CURIE , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , UNIVERSITE PIERRE ET MARIE CURIE , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- 申请人地址: FR Paris FR Paris FR Paris FR Paris FR Paris
- 专利权人: Theravectys,Institut Curie,Centre National de la Recherche Scientifique,Sorbonne Universite,Institut National de la Sante et de la Recherche Medicale (INSERM)
- 当前专利权人: Theravectys,Institut Curie,Centre National de la Recherche Scientifique,Sorbonne Universite,Institut National de la Sante et de la Recherche Medicale (INSERM)
- 当前专利权人地址: FR Paris FR Paris FR Paris FR Paris FR Paris
- 代理机构: W&C IP
- 优先权: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@34d35fc4
- 国际申请: PCT/EP2015/067090 WO 20150724
- 国际公布: WO2016/012623 WO 20160128
- 主分类号: C07K16/30
- IPC分类号: C07K16/30 ; G01N33/574 ; C07K16/28 ; C07K14/705 ; C12N5/0783 ; A61K35/17 ; C07K16/00 ; A61K38/00
摘要:
The invention relates to the regulated expression of a chimeric antigen receptor (CAR) within a lentiviral vector. The CAR comprises a hook-binding domain that interacts with a hook, preferably encoded by the same lentiviral vector, which prevents proper processing and release of the CAR to the cell membrane. The invention encompasses vectors, methods of making the vectors, and methods of using them, including medicinal uses. The vectors can be used for administration to humans to induce immune responses and to treat cancers and tumors.
公开/授权文献
信息查询